HIV belongs to a family of viruses known as retroviruses. The ability of retroviruses to synthesize DNA using their RNA genome as a template distinguishes them from other viruses. The synthesized DNA can then integrate itself into the genome of an infected cell, becoming what is known as a provirus. Jan Svoboda, a cell and molecular biologist at the Czech Academy of Sciences, who was elected to the National Academy of Sciences in 2015, has spent over half a century studying the mechanisms of retrovirus infection. His pioneering work in the 1960s with the Rous sarcoma virus, a retrovirus that causes tumors in chickens, provided some of the first definitive evidence for provirus integration into the host cell genome. In his Nobel lecture, virologist Howard Temin of the University of Wisconsin-Madison, who proposed the existence of the provirus in 1960 and won the Nobel Prize for Medicine in 1975, acknowledged Svoboda's independent proposal of the provirus concept (1). Svoboda recently spoke to PNAS about his scientific work, as well as his experiences as a scientist in the Czech Republic both during and after Communist Rule.
PNAS:
The Rous sarcoma virus has been your experimental system of choice for decades. How did you become interested in studying this virus?
Svoboda: I had been attracted to biology for many years before. I read a lot and I also had been actively engaged in experimentation, and fortunately I had been accepted to study the natural sciences.
To do work in cell biology, it was required to work in tissue culture. And the only place which had been interested in tissue culture had been Dr. Keilova's laboratory at the biological institute of the Academy [Czechoslovak Academy of Sciences]. I went there and learned how to handle the tissue cultures, especially how to handle tumor cell growth. And in this laboratory I also first came in contact with the Rous sarcoma virus. I had been so impressed by the fact that once you infect the cell with the virus, it becomes fully changed in a few days. So this was my inspiration and start.
PNAS: What, in your view, has been the biggest impact of your work?
Svoboda: Because I had been so deeply concentrated on this one tumor line derived from rat tumor induced with chicken Rous sarcoma virus, it paid off very much and led to the very clear-cut conclusion that the Rous sarcoma virus, being an RNA virus, can become integrated in the cell genome, in a fixed way, as a provirus. And I think this was of the greatest importance, and this was reflected also by Howard Temin. I highly value, also, the clear-cut definition of the fact that to get maturation of the retrovirus in nonpermissive cells, for example mammalian cells infected with avian virus, you can complement it by fusion with cells, which are sensitive to the virus. This was clear-cut indication that cell factors are involved and important in the control of retrovirus infection.
PNAS: How does your work inform strategies for treating retroviral infections?
Svoboda: The simpleminded approach that just by chemical inhibition we can get rid of retrovirus infection is not right, as we know now, because retroviruses-HIV included-get integrated in the cell genome. And for quite a long time they can become silent. They don't produce anything; they don't go through rounds of replication, so chemicals can't act on the viruses. And therefore we have to find new approaches: how to get rid of a viral genome which became a part of the cell genome.
PNAS: You've spent most of your scientific career in the Czech Republic. What are the particular challenges to doing science in resource-limited countries?
Svoboda: In the small countries, you can't cover all topics. In a small country you have to concentrate on original-minded approaches, on people who are creative, who are highly knowledgeable, who are able to Jan Svoboda. Image courtesy of Miluska Snaibergova.
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